Facet Wealth Inc. Purchases New Stake in Axon Enterprise, Inc $AXON

Facet Wealth Inc. purchased a new stake in Axon Enterprise, Inc (NASDAQ:AXON) during the 2nd quarter, Holdings Channel reports. The institutional investor purchased 285 shares of the biotechnology company’s stock, valued at approximately $215,000.

Other institutional investors have also modified their holdings of the company. TCTC Holdings LLC raised its stake in shares of Axon Enterprise by 75.0% in the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after purchasing an additional 24 shares in the last quarter. Bartlett & CO. Wealth Management LLC raised its stake in Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock valued at $31,000 after buying an additional 33 shares in the last quarter. Banque Transatlantique SA acquired a new stake in Axon Enterprise during the first quarter valued at approximately $31,000. Catalyst Capital Advisors LLC acquired a new stake in Axon Enterprise during the first quarter valued at approximately $32,000. Finally, Flaharty Asset Management LLC acquired a new stake in shares of Axon Enterprise during the 1st quarter valued at approximately $33,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Weiss Ratings reissued a “hold (c)” rating on shares of Axon Enterprise in a research report on Wednesday, October 8th. Northland Securities set a $800.00 target price on shares of Axon Enterprise in a report on Tuesday, August 5th. Craig Hallum raised shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 target price on the stock in a report on Tuesday, August 5th. UBS Group reiterated a “neutral” rating and set a $840.00 price objective (up previously from $820.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Finally, Piper Sandler assumed coverage on shares of Axon Enterprise in a research note on Tuesday, September 23rd. They set an “overweight” rating and a $893.00 price objective on the stock. Fourteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $841.64.

Axon Enterprise Stock Up 1.8%

AXON stock opened at $749.00 on Tuesday. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a fifty-two week low of $422.38 and a fifty-two week high of $885.91. The firm’s 50-day simple moving average is $732.32 and its 200 day simple moving average is $727.76. The stock has a market cap of $58.80 billion, a PE ratio of 184.94, a price-to-earnings-growth ratio of 28.58 and a beta of 1.41.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The business had revenue of $668.54 million for the quarter, compared to analysts’ expectations of $641.77 million. During the same quarter last year, the company earned $1.20 EPS. The company’s revenue for the quarter was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, sell-side analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Insider Buying and Selling

In related news, CAO Jennifer H. Mak sold 77 shares of the firm’s stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $760.00, for a total value of $58,520.00. Following the sale, the chief accounting officer directly owned 15,003 shares in the company, valued at $11,402,280. This trade represents a 0.51% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Joshua Isner sold 15,919 shares of the firm’s stock in a transaction on Friday, August 15th. The shares were sold at an average price of $746.26, for a total value of $11,879,712.94. Following the transaction, the president directly owned 238,379 shares in the company, valued at $177,892,712.54. This trade represents a 6.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 59,932 shares of company stock valued at $45,115,616 in the last ninety days. Insiders own 4.40% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.